EZH2 and acute myeloid leukemia: Additionally, circadian clock protein BMAL1 enhances methylation of the early B-cell factor 3 (EBF3) promoter via EZH2 and suppresses its expression, inhibiting ferroptosis processes, thus promoting AML progression (Wang et al., 2023b).